LDHA (lactate dehydrogenase A) is frequently upregulated in clinical tumors to support the high glycolytic activity, and high expression has been thought to be responsible for many cancers, such as glioblastoma, pancreatic, and some kidney cancers. This evidence concerns the gene LDHA and kidney cancer.